LEADER 00979nam0-22003131i-450-
001 990004017200403321
005 20051102133514.0
035   $a000401720
035   $aFED01000401720
035   $a(Aleph)000401720FED01
035   $a000401720
100   $a19990604d1983----km-y0itay50------ba
101 0 $aita
105   $ay-------00-e-
200 1 $aAlle origini della nuova logica$eCarteggio scientifico con Hilbert Husserl, Peano Russell Vailati [et al.]$gA cura di G. Gabriel [et al.]$fGottlob Frege
210   $aTorino$cBoringhieri$dc1983
215   $aXXXI, 288 p.$d22 cm
225 1 $aLectio
305   $aEd.orig.: Amburgo, 1976
676   $a160$v21$zita
700  1$aFrege,$bGottlob$f<1848-1925>$04796
702  1$aGabriel,$bGottfried
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990004017200403321
952   $a160 FRE 1$bDip.Filos.323$fFLFBC
959   $aFLFBC
996   $aAlle origini della nuova logica$977929
997   $aUNINA

LEADER 01723nam  2200421Ia 450 
001 9910695979303321
005 20070716160029.0
035   $a(CKB)5470000002374005
035   $a(OCoLC)155854244
035   $a(EXLCZ)995470000002374005
100   $a20070716d2007      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug safety$b[electronic resource] $efurther actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /$fstatement of Marcia Crosse
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2007]
215   $a13 pages $cdigital, PDF file
225 1 $aTestimony ;$vGAO-07-856 T
300   $aTitle from title screen (viewed on July 3, 2007).
300   $a"For release ... May 9, 2007."
300   $aPaper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
320   $aIncludes bibliographical references.
517   $aDrug safety 
606   $aDrugs$xSafety measures
606   $aDrugs$xSafety measures$xGovernment policy$zUnited States
615  0$aDrugs$xSafety measures.
615  0$aDrugs$xSafety measures$xGovernment policy
700   $aCrosse$b Marcia$01380679
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Health.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695979303321
996   $aDrug safety$93449630
997   $aUNINA